Which of tobacco, alcohol or illicit drugs imposes the greatest burden on society: A comparison of the social cost of substance abuse in Switzerland Prof.

Slides:



Advertisements
Similar presentations
Economic and Public Health Benefits of Coal-Based Electric Energy 20 th Annual Surface Mined Land Reclamation Technology Transfer Seminar Jasper, IN December.
Advertisements

Session 1 Introduction to course. Session 1 structure 1.Why are mental health promotion and mental disorder prevention important? 2. Contents of this.
GAP Report 2014 People with disabilities People left behind: People with disabilities Link with the pdf, People with disabilities.
Substance Use Disorder Treatment Supporting the Field with Evidence and Logic.
©2013 Australian Indigenous HealthInfoNet 1 Key facts Overview of Australian Indigenous health status 2012.
INTANGIBLE COSTS OF ALCOHOL DEPENDENCY AS A PUBLIC GOOD: AN ESTIMATE FOR SWITZERLAND BASED ON CONTINGENT VALUATION SURVEY Sonia Pellegrini, Claude Jeanrenaud.
The development of an Australian drug policy index Assoc Prof Alison Ritter Director, Drug Policy Modelling Program (DPMP) University of New South Wales.
Poor Bipolar Outcome The Effect of Substance Abuse On Bipolar Disorder Phillip Long M.D.
Professor Eddie Kane.
Kidane Asmerom and Teh wei-Hu
Curbing the Epidemic: Governments and the Economics of Tobacco Control: Global, Regional and Hungarian Evidence By Annette Dixon Sector Director World.
317_L24, Mar 11/08, J. Schaafsma 1 Review of the Last Lecture are discussing shadow pricing in the context of cost-benefit analysis noted that shadow pricing.
Valuing the intangible costs of alcohol dependence A contingent valuation study Sonia Pellegrini Claude Jeanrenaud Institute for Economic and Regional.
The Prevalence of Mental Illness
Lec 21, Project Evaluation Part 1: Impact analysis General characteristics of benefits and costs Estimates of economic costs and benefits A framework for.
Valuation issues Jan Sørensen, Health Economist CAST – Centre for Applied Health Services Research and Technology Assessment University of Southern Denmark.
Substance Use and Recessions: Insights from Economic Analyses of Alcohol and Drug Use Rosalie Liccardo Pacula, Ph.D. Co-Director RAND Drug Policy Research.
Chapter Twelve Importance of Noncommunicable Disease.
1 Adolescent Mental Health: Key Data Indicators Gwendolyn J. Adam, Ph.D., L.C.S.W. Assistant Professor - Department of Pediatrics Section of Adolescent.
Cost Assessment Usa Chaikledkaew, Ph.D..
Indicators of health and disease frequency measures
Cost Program: Barbados Experience
Poverty and Environmental Impacts of Electricity Price Reforms in Montenegro prepared by Dragana Radevic CEED, Montenegro Fourth Poverty Reduction Strategies.
 2007 Johns Hopkins Bloomberg School of Public Health Section B A Look Ahead: Summary of Main Findings.
Financing Health Promotion in Southeast Asia Does it match with current and future challenges? Phusit Prakongsai, Kanitta Budhamcharoen, Kanjana Tisayatikom,
TOBACCO PREVENTION AND CONTROL PROGRAM Mike Maples, Assistant Commissioner Mental Health and Substance Abuse Services.
Annual report 2010: the state of the drugs problem in Europe.
 2007 Johns Hopkins Bloomberg School of Public Health The Costs of Smoking Hana Ross, PhD American Cancer Society and the International Tobacco Evidence.
Pathways to risk: What can we do? Ian Webster. “Ways of Seeing” Moral - legal issue Health - public health problem Psychosocial problems - education A.
NHPA Mental Health. According to the World Health Organization, mental health is defined as a ‘state of wellbeing in which every individual realises his.
©2012 Australian Indigenous HealthInfoNet1 Overview of Australian Indigenous health status 2011 Key facts.
Grace and Alanah. National Health Priority Areas. Cancer.
Alcohol policy in Catalonia Joan Colom Antoni Gual Lidia Segura March 2007, Pécs, Baranya (H)
Valuing intangible costs of substance abuse in monetary terms Claude Jeanrenaud, Sonia Pellegrini IRER, University of Neuchâtel Neuchâtel October 25 th,
Unit 3 Health and Human Development Revision Class.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 6: Cost-effectiveness analysis – Part.
Decide if each question is TRUE or FALSE. AAAA single drink of alcohol can affect you. True  A A
Damage and Losses Evaluation in Cases of Disasters An Introduction to the ECLAC methodology J. Roberto Jovel, Consultant.
What are the economic consequences of adult ill- health in Russia? Marc Suhrcke WHO European Office for Investment for Health and.
1 An Introduction to the Minnesota Epidemiological Profile Minnesota State Epidemiological Workgroup and Minnesota Institute of Public Health Fall Forums.
Market Efficiency and Market Failure Autumn 2011.
Quality of life of alcohol-related diseases and road accidents in Switzerland: An economic assessment France Priez The University of North Carolina at.
Human costs of tobacco-related diseases * Marco Vannotti, France Priez, Claude Jeanrenaud, Jean-Pierre Zellweger Institut de recherches économiques et.
Alcoholtaxessavelives.org Julie Martinez, Chris Weathers, Cassandra Romero.
The financial costs and benefits of alcohol The financial costs and benefits of alcohol Christine Godfrey Department of Health Sciences & Centre for Health.
Drugs and Our Society Drug Taking Behavior Part 2.
WHO activities related to WHA58.26 | 11. August |1 | WHA resolution on alcohol (2005): background and follow up activities by the WHO Secretariat.
The Global Situation: Occupational Injuries and Diseases
National Health Policy Conference AcademyHealth & Health Affairs Panel on Consequences of Uninsurance January 28, 2004.
Valuing psychological and behavioural effects of alcohol dependence : A contingent valuation study Claude Jeanrenaud 1,2, Sonia Pellegrini 1, Nicolas Marmagne.
Peterson-Kaiser Health System Tracker What are recent trends in cancer spending and outcomes?
Peterson-Kaiser Health System Tracker What do we know about social determinants of health in the U.S. and comparable countries?
1 Psychology 320: Psychology of Gender and Sex Differences March 14 Lecture 55.
Tobacco attributable hospitalizations in BC; geographic variations, temporal trends and burden relative to alcohol and illicit drugs Jane Buxton
The Gender Gap: Health Care Disparities between Men and Women By Maria Psilis.
Farid Abolhassani What is economic evaluation 16.
{ Binge drinking in Australia Especially for teenagers.
Alcohol screening and brief interventions in primary care Dr Richard Watson.
Traveller Health Needs Traveller Health Statistics.  Travellers have more than double the natural rate of still births.  Infant mortality rates are.
World Health Organization
DR GHULAM NABI KAZI WHO Country Office Pakistan
Lessons from the United States Experience with Tobacco Taxes
The Burden of Tobacco Use
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Comparison of data from WBE with other sources
Module 1: Putting Drugs of Abuse and Clients in Perspective
MEASURING HEALTH STATUS
Discounting Future Benefits and Costs
Global Burden of Tobacco
The Costs of Smoking Hana Ross, PhD
Presentation transcript:

Which of tobacco, alcohol or illicit drugs imposes the greatest burden on society: A comparison of the social cost of substance abuse in Switzerland Prof. Claude Jeanrenaud Sonia Pellegrini Gaëlle Widmer Venice, March 18-20, 2005 FINANCING MENTAL AND ADDICTIVE DISORDERS Institute of Economic and Regional Research University of Neuchâtel, Switzerland

Research questions How do tobacco, alcohol and illicit drug social cost compare? Are the results of the Swiss study consistent with previous work?

Vitale et al. (1998) The social cost of tobacco consumption in Switzerland, University of Neuchâtel. Jeanrenaud et al. (2003) The social cost of alcohol abuse in Switzerland, University of Neuchâtel. Jeanrenaud et al. (2005) The social cost of illicit drug use in Switzerland, University of Neuchâtel. Three recent works on the social cost of substance abuse in Switzerland have been commissioned by the Swiss Federal Office of Public Health. The same analytical framework and the same methodology were applied in the three studies. However, the reference year is 1995 for the tobacco work, 1998 for the alcohol study and 2000 for the study on illicit drug. We didn’t adjust the results for change in the price level. The price increase has been very moderate between 1995 and 2000.

What does “social cost” of substance abuse really mean? All health and non health implications of substance abuse. Adverse effect are borne by users, by users’ relatives, by the community at large. Tangible and intangible effects are part of the social burden. Social cost of substance abuse reflect a loss in welfare for the population.

Main cost categories Direct costs: they correspond to the resources that are diverted to medical treatment, therapy, law enforcement, prevention, and are thus no longer available for other beneficial use. Indirect costs: they reflect the value of the production that is not made available to the society as a consequence of work impairment or premature death. Indirect costs correspond to the value of the forgone production.

Most previous studies on drugs only value direct and indirect cost when estimating the social cost of substance abuse. The assessment of these (tangible) cost categories is straightforward, as we can use market prices to estimate the value of the resources used or foregone. A change in health state with its consequences on the quality of life of drug users and their relatives is a significant part of the social burden of drug use. It is not possible to rely on some market price to express intangible cost in monetary terms.

Cost assessment method Two broad categories of method : preference-based (or willingness-to-pay) vs. non preference-based (or production based-method). Direct cost : treatment cost method, replacement cost method. Indirect cost : human capital (discounted value of actual and future forgone production). Human cost : contingent valuation method is a willingness-to- pay method based on a hypothetical market.

When using simultaneously production based-methods and a willingness-to-pay method there is a risk of double counting. The contingent valuation method measures the maximum amount that an individual is prepared to pay in order to reduce a specific health risk and avoid its consequences, including a drop in income or additional out-of-pocket payments for medical treatment. The contingent valuation survey has to be carefully designed in order to limit the assessment of quality-of-life change.

Epidemiological data

Premature death caused by illicit drugs affect young people (average age 31.8 years). Approximately 35 productive life years lost on average per drug attributable death. Average life years lost per case attributable to alcohol is 13,3 (the leading cause of acute premature death caused by alcohol is motor vehicle accident). The average the average loss of life years per death attributable to smoking is 6 years, which means than on the average, people die from smoking after the official age of retirement (64 for women and 65 for men).

Result: direct cost Is the product turnover a part of the social cost? Is money spent for prevention to be added to the social cost?

For different reasons, treatment cost for tobacco and alcohol related diagnoses are underestimated. There are no estimate of fire smoking-related fire losses. Responsibility of alcohol in car accident is often not reported. Limited resources are devoted to prevention. Illicit drug policy clearly set priority on repression.

Result: production losses

Mortality cost is the present value of lost earnings (or production) due to premature death. Morbidity cost is the production lost through work impairment, reduced efficiency at work or a higher risk of being unemployed. Illicit drugs morbidity cost are four times higher than those related to alcohol. In the Swiss study data on short or long term work impairment caused by alcohol related diagnoses were not available ; the morbidity cost is then a very conservative value.

Result: loss in quality of life Valuing quality of life change Method : contingent valuation survey. Face to face interviews. Framing : ex-ante insurance-based question (tobacco, alcohol) and ex-post user-based question (alcohol, illicit drug). Elicitation techniques : paiement cards.

Quality of life cost Human cost correspond to the monetary equivalent of the quality of life change for the consumer and his or her relatives. Quality of life loss per case for alcohol (CHF 12’000) and illicit drug (CHF 13’040) are quite similar. Households would be willing to accept a significant reduction in income for a (hypothetical) perfect treatment for a member of the household. The lower cost per case for tobacco (CHF 2’540) was expected. TobaccoAlcoholIllicit drugs* Physiopathological effects Psychosocial and behavioural effects Total * Dependency to heroïne and cocaïne ** Psychosocial and behavioural effects : alcohol dependant person only Human cost : loss in quality of life

How do social burden of tobacco, alcohol and illicit drug compare

The highest global burden is caused by tobacco (almost CHF 10 billions). Part of the difference between alcohol and tobacco global burden is due to the lack of quantitative data on behavioural effect of alcohol (productivity at work, violence…). There are three main reasons for the relatively high burden caused bye illicit drugs: the huge resources devoted to law enforcement, the high proportion of drug dependant individuals who are not working for many years, most death are of young man or woman (on average just over 30).

Cost per case The marginal benefit of a prevention program is the highest for illicit drug, followed by alcohol and tobacco.

Comparison with previous work

The values need not be the same as the prevalence of substance use vary significantly across countries. The convergence is good for tobacco (tangible cost make between 1.1 and 1.4 percent of GDP). The alcohol-related costs for Australia, Canada, and France are very close (between 1.0 and 1.2 of GDP for tangible). Switzerland (low value for alcohol-related cost) and United States (high value) are outliers.

Discussion The social cost of substance abuse is an issue of key interest to policy makers. The priorities in health policies and the allocation of resources (to prevention, research, dependence therapy) should reflect the importance substance use as a public health problem. Social cost is a central element to evaluate the severity of a public health problem. Are the cost estimates reliable? Is the burden of smoking really 50% higher than the burden of alcohol abuse? Is there not a risk of bias in the estimate due to the unequal availability of data (frequency and impact)? It would mean that the burden of alcohol and illicit drug is underestimated. The severity of a health problem also depends of the availability of effective methods to deal with the problem. The proper indicator would then be the avoidable cost rather than the social cost.